Wavely Diagnostics Raises $1.35MM in Funding to Accelerate Commercial Launch of Digital Diagnostics Platform for Childhood Ear Infections

Wavely Diagnostics, a digital diagnostics company, has recently secured $1.35 million in funding to further advance its digital diagnostics platform for virtual pediatric care. With this latest round of funding, Wavely's total funding raised now stands at an impressive $6.35 million. The additional funds will be instrumental in expediting the commercial launch of their smartphone-based app desig..

  • format_list_bulleted Pharmacology/BS
  • · 2023. 7. 13.
  • textsms

Shorla Oncology Announces Licensing Agreement and Strategic Partnership for Rights to Market Chemotherapy Drug, PIP-101, in the United States

Shorla Oncology Announces Licensing Agreement and Strategic Partnership for Rights to Market Chemotherapy Drug, PIP-101, in the United States &nbsp The developer is a United Kingdom-based drug development and manufacturing company, providing integrated R&D and manufacturing capabilities to accelerate entry of PIP-101 in the U.S. market. Shorla Oncology to receive the exclusive rights to commerci..

  • format_list_bulleted Pharmacology/BS
  • · 2023. 7. 7.
  • textsms